CellaVision AB (publ) (CLVSF)
OTCMKTS · Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025

CellaVision AB Market Cap

CellaVision AB has a market cap or net worth of $469.60 million as of June 13, 2025. Its market cap has decreased by -18.07% in one year.

Market Cap
469.60M
Enterprise Value
452.80M
Revenue
74.51M
Ranking
n/a
PE Ratio
30.99
Stock Price
$19.28

Market Cap Chart

Since May 28, 2007, CellaVision AB's market cap has increased from 54.35M to 469.60M, an increase of 764.01%. That is a compound annual growth rate of 12.68%.

History

DateMarket Cap% Change
Jun 13, 2025469.60M-0.02%
Dec 30, 2024469.69M-6.32%
Dec 29, 2023501.37M-4.32%
Dec 30, 2022523.98M-38.89%
Dec 30, 2021857.50M-4.04%
Dec 30, 2020893.58M9.30%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo, Inc. 1.59B
Veradigm 764.23M
Elite Pharmaceuticals 717.88M
Nika Pharmaceuticals 708.22M
Tian'an Technology Group 637.25M
CytoDyn 441.29M
Northwest Biotherapeutics 403.72M
Glass House Brands 384.13M
Market Cap Rankings